Scienture Holdings, Inc.
corporate_fare Company Profile
Scienture Holdings, Inc. (NASDAQ:SCNX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 24 items for SCNX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-02, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 12 rated 8 or above. Recent SEC coverage for SCNX spans 10-Q, 8-K, 10-K/A.
Recent high-impact activity:
- Arbli™ Lands Formulary Wins at Three Top Pediatric Hospitals
- Scienture Announces 1-for-25 Reverse Split to Regain Nasdaq Compliance
- Scienture Inks Exclusive Distribution Deal for REZENOPY Across 2,000 Addiction Treatment Centers
- Scienture Q2 Revenue Jumps 510% Sequentially to $344K, Loss Narrows 58%
- Scienture Holdings Q2 2026: Revenue Ramps, Going Concern Doubt Alleviated
Financial Snapshot
Short Interest & Short Volume
1.18 days to coverFINRA reported short interest of 1,249,889 shares in SCNX as of the September 15, 2026 settlement, a 22.3% increase from the prior period — about 1.2 days to cover at its recent average daily volume. On October 1, 2026, 22.9% of SCNX volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.